Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Net Margin (2016 - 2025)

Historic Net Margin for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to 15.05%.

  • Collegium Pharmaceutical's Net Margin rose 91900.0% to 15.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.72%, marking a year-over-year decrease of 70600.0%. This contributed to the annual value of 6.71% for FY2024, which is 14100.0% down from last year.
  • As of Q3 2025, Collegium Pharmaceutical's Net Margin stood at 15.05%, which was up 91900.0% from 6.37% recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Net Margin ranged from a high of 89.23% in Q2 2021 and a low of 91.49% during Q4 2021
  • For the 5-year period, Collegium Pharmaceutical's Net Margin averaged around 5.49%, with its median value being 6.89% (2024).
  • Per our database at Business Quant, Collegium Pharmaceutical's Net Margin crashed by -1006100bps in 2021 and then soared by 859400bps in 2022.
  • Over the past 5 years, Collegium Pharmaceutical's Net Margin (Quarter) stood at 91.49% in 2021, then skyrocketed by 94bps to 5.55% in 2022, then skyrocketed by 484bps to 21.33% in 2023, then tumbled by -68bps to 6.89% in 2024, then surged by 118bps to 15.05% in 2025.
  • Its Net Margin stands at 15.05% for Q3 2025, versus 6.37% for Q2 2025 and 1.36% for Q1 2025.